Flora Rajaei, Cristian Minoccheri, Emily Wittrup, Richard C Wilson, Brian D Athey, Gilbert S Omenn, Kayvan Najarian
{"title":"AI-based Computational Methods in Early Drug Discovery and Post Market Drug Assessment: A Survey.","authors":"Flora Rajaei, Cristian Minoccheri, Emily Wittrup, Richard C Wilson, Brian D Athey, Gilbert S Omenn, Kayvan Najarian","doi":"10.1109/TCBB.2024.3492708","DOIUrl":null,"url":null,"abstract":"<p><p>Over the past few years, artificial intelligence (AI) has emerged as a transformative force in drug discovery and development (DDD), revolutionizing many aspects of the process. This survey provides a comprehensive review of recent advancements in AI applications within early drug discovery and post-market drug assessment. It addresses the identification and prioritization of new therapeutic targets, prediction of drug-target interaction (DTI), design of novel drug-like molecules, and assessment of the clinical efficacy of new medications. By integrating AI technologies, pharmaceutical companies can accelerate the discovery of new treatments, enhance the precision of drug development, and bring more effective therapies to market. This shift represents a significant move towards more efficient and cost-effective methodologies in the DDD landscape.</p>","PeriodicalId":13344,"journal":{"name":"IEEE/ACM Transactions on Computational Biology and Bioinformatics","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE/ACM Transactions on Computational Biology and Bioinformatics","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1109/TCBB.2024.3492708","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Over the past few years, artificial intelligence (AI) has emerged as a transformative force in drug discovery and development (DDD), revolutionizing many aspects of the process. This survey provides a comprehensive review of recent advancements in AI applications within early drug discovery and post-market drug assessment. It addresses the identification and prioritization of new therapeutic targets, prediction of drug-target interaction (DTI), design of novel drug-like molecules, and assessment of the clinical efficacy of new medications. By integrating AI technologies, pharmaceutical companies can accelerate the discovery of new treatments, enhance the precision of drug development, and bring more effective therapies to market. This shift represents a significant move towards more efficient and cost-effective methodologies in the DDD landscape.
期刊介绍：
IEEE/ACM Transactions on Computational Biology and Bioinformatics emphasizes the algorithmic, mathematical, statistical and computational methods that are central in bioinformatics and computational biology; the development and testing of effective computer programs in bioinformatics; the development of biological databases; and important biological results that are obtained from the use of these methods, programs and databases; the emerging field of Systems Biology, where many forms of data are used to create a computer-based model of a complex biological system
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
